Julian Hong, MD, MS

Title(s)Associate Professor, Radiation Oncology
SchoolSchool of Medicine
PronounsHe/Him/His
ORCID ORCID Icon0000-0001-5172-6889 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford University, Stanford, CABS06/2008Biomedical Computation
    Stanford University, Stanford, CAMS06/2009Bioengineering
    University of Wisconsin-Madison, Madison, WIMD05/2014Medicine
    Yale-New Haven Medical Center, New Haven/Waterbury, CTInternship06/2015Internal Medicine
    Duke University Medical Center, Durham, NCResidency06/2019Radiation Oncology
    Duke University Medical Center, Durham, NCChief Residency06/2019Radiation Oncology
    Collapse Awards and Honors
    American Medical Informatics Association (AMIA)2024Scientific Program Committee Award
    Kaggle March Machine Learning Mania 20222022Bronze Medal
    Radiation Oncology Institute2021Publication Award
    Cambridge Healthtech Institute2021Bio-IT World Innovative Practices Award
    American Medical Informatics Association (AMIA)2021Annual Symposium Distinguished Poster
    Symposium on Artificial Intelligence for Learning Health Systems2020New England Journal of Medicine Travel Scholarship/Spotlight Talk
    Google Cloud Kaggle NCAA March Madness Machine Learning Competition20183rd Place
    University of Wisconsin2014Dylan Cappel Memorial Scholarship in Oncology
    University of Wisconsin2012Herman and Gwendolyn Shapiro Excellence in Student Research Award

    Collapse Overview 
    Collapse Overview
    Dr. Hong is Associate Professor and Medical Director of Radiation Oncology Informatics in the Department of Radiation Oncology, Division of Clinical Informatics and Digital Transformation (DoC-IT), and Bakar Computational Health Sciences Institute at the University of California, San Francisco, and in the UCSF-UC Berkeley Joint Program in Computational Precision Health. Clinically, he specializes in the treatment of genitourinary malignancies.

    Dr. Hong’s NIH-funded informatics research program focuses on the development and implementation of computational tools in the clinic to provide personalized, precision cancer care for patients. His group combines clinical domain knowledge with data science expertise to generate insights from real world data, develop actionable artificial intelligence-based tools, and implement and evaluate the benefit of these advances in patient care. He led one of the first randomized controlled studies of healthcare machine learning, developing an electronic health record-based algorithm that accurately directed care to reduce emergency visits and hospitalizations during radiotherapy.

    Dr. Hong received his B.S. in Biomedical Computation and M.S. in Bioengineering from Stanford University. He completed his M.D. at the University of Wisconsin and residency in radiation oncology at Duke University, where he served as Chief Resident. Dr. Hong is board certified in both radiation oncology and clinical informatics.

    On a national level, Dr. Hong serves on the NRG Oncology Cancer Care Delivery Research Committee, American Society of Clinical Oncology (ASCO) Cancer Communications Committee and AI Community of Practice Steering Committee, American Society for Radiation Oncology (ASTRO) Scientific Review Panel, Radiation Oncology Institute Research Committee, and American Medical Informatics Association Scientific Program Committee.

    Dr. Hong’s research has been published in high-impact, peer-reviewed journals such as the Journal of Clinical Oncology, JAMA Oncology and the New England Journal of Medicine AI. His work has been recognized with the Radiation Oncology Institute (ROI) Publication Award, Bio-IT World Innovative Practices Award, and the Symposium on Artificial Intelligence for Learning Health Systems New England Journal of Medicine Travel Award. He finished third in a pool of 934 teams in the 2018 Google Cloud Kaggle NCAA March Madness Learning Competition.
    Collapse Mentoring

    Collapse Research 
    Collapse Research Activities and Funding
    Multi-institutional validation of a multi-modal machine learning algorithm to predict and reduce acute care during cancer therapy
    NIH/NCI R01CA277782Mar 1, 2023 - Feb 29, 2028
    Diagnostic tools for quality improvement of machine learning-based clinical decision support systems
    Patient-Centered Outcomes Research Institute (PCORI) Improving Methods for Conducting Patient-CenteredMar 1, 2023 - Mar 25, 2027
    Advancing the Drug Development Process in Metastatic Prostate Cancer through Machine Learning
    Prostate Cancer Foundation 22CHAS02Sep 6, 2022 - Sep 5, 2024
    Artificial intelligence approaches to reduce disparities in supportive care during cancer therapy
    UCSF Computational Cancer AwardSep 1, 2021 - Feb 28, 2023
    Role: Principal Investigator
    Artificial intelligence approaches for the diagnosis and treatment of oligometastatic prostate cancer
    ASTRO-PCF Career Development Award to End Prostate CancerJul 1, 2021 - Jun 30, 2024
    Role: Principal Investigator
    Accessible and equitable computational approaches to reduce acute care for cancer patients
    Conquer Cancer Career Development GrantJul 1, 2021 - Jun 30, 2024
    Role: Principal Investigator
    Reducing preventable ED visits and hospitalizations in patients with cancer
    UCSF Precision Medicine Cancer Building AwardJul 1, 2020 - Jun 30, 2022
    Role: Principal Investigator
    Enhanced prostate cancer diagnostics: Intelligent algorithms to improve patient
    American Cancer Society IRG-17-180-19Feb 1, 2020 - Jan 31, 2021
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications

    Collapse Featured Content 
    Collapse Featured Presentations
      Collapse Twitter
      Collapse Featured Videos

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
      Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
      Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
      1. Unplanned Hospitalization Prediction During Chemoradiotherapy Via Machine Learning Classifiers-Reply. JAMA Oncol. 2024 Aug 29. Feng J, Friesner I, Hong JC. PMID: 39207748.
        View in: PubMed   Mentions:
      2. Delayed definitive management of localized prostate cancer: what do we know? Prostate Cancer Prostatic Dis. 2024 Aug 11. Mohamad O, Li YR, Feng F, Hong JC, Wong A, El Kouzi Z, Shelan M, Zilli T, Carroll P, Roach M. PMID: 39128937.
        View in: PubMed   Mentions:    Fields:    
      3. AI Use in Prostate Cancer: Potential Improvements in Treatments and Patient Care. Oncology (Williston Park). 2024 05 13; 38(5):208-209. Hong JC. PMID: 38776517.
        View in: PubMed   Mentions:    Fields:    Translation:Humans
      4. Machine Learning-Based Prediction of Hospitalization During Chemoradiotherapy With Daily Step Counts. JAMA Oncol. 2024 May 01; 10(5):642-647. Friesner ID, Feng J, Kalnicki S, Garg M, Ohri N, Hong JC. PMID: 38546697; PMCID: PMC10979356.
        View in: PubMed   Mentions: 1     Fields:    Translation:Humans
      5. Health Care Cost Reductions with Machine Learning-Directed Evaluations during Radiation Therapy - An Economic Analysis of a Randomized Controlled Study. NEJM AI. 2024 Apr; 1(4). Natesan D, Eisenstein EL, Thomas SM, Eclov NCW, Dalal NH, Stephens SJ, Malicki M, Shields S, Cobb A, Mowery YM, Niedzwiecki D, Tenenbaum JD, Palta M, Hong JC. PMID: 38586278; PMCID: PMC10997376.
        View in: PubMed   Mentions:
      6. Determinants of Symptomatic Intracranial Progression After an Initial Stereotactic Radiosurgery Course. Adv Radiat Oncol. 2024 Jun; 9(6):101475. Leng JX, Carpenter DJ, Huang C, Qazi J, Arshad M, Mullikin TC, Reitman ZJ, Kirkpatrick JP, Floyd SR, Fecci PE, Chmura SJ, Hong JC, Salama JK. PMID: 38690297; PMCID: PMC11059392.
        View in: PubMed   Mentions:
      7. Natural Language Processing for Radiation Oncology: Personalizing Treatment Pathways. Pharmgenomics Pers Med. 2024; 17:65-76. Lin H, Ni L, Phuong C, Hong JC. PMID: 38370334; PMCID: PMC10874185.
        View in: PubMed   Mentions:
      8. Ctrl-C: a cross-sectional study of the electronic health record usage patterns of US oncology clinicians. JNCI Cancer Spectr. 2023 Aug 31; 7(5). Sinha S, Holmgren AJ, Hong JC, Rotenstein LS. PMID: 37688578; PMCID: PMC10555739.
        View in: PubMed   Mentions:    Fields:    
      9. Unlocking the Power of ChatGPT, Artificial Intelligence, and Large Language Models: Practical Suggestions for Radiation Oncologists. Pract Radiat Oncol. 2023 Nov-Dec; 13(6):e484-e490. Waters MR, Aneja S, Hong JC. PMID: 37598727.
        View in: PubMed   Mentions: 2     Fields:    Translation:Humans
      10. Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical Prostatectomy. Eur Urol Focus. 2024 Jan; 10(1):66-74. Sabbagh A, Tilki D, Feng J, Huland H, Graefen M, Wiegel T, Böhmer D, Hong JC, Valdes G, Cowan JE, Cooperberg M, Feng FY, Mohammad T, Shelan M, D'Amico AV, Carroll PR, Mohamad O. PMID: 37507248.
        View in: PubMed   Mentions:    Fields:    Translation:Humans
      11. Identification of Key Elements in Prostate Cancer for Ontology Building via a Multidisciplinary Consensus Agreement. Cancers (Basel). 2023 06 08; 15(12). Moreno A, Solanki AA, Xu T, Lin R, Palta J, Daugherty E, Hong D, Hong J, Kamran SC, Katsoulakis E, Brock K, Feng M, Fuller C, Mayo C, BDSC Prostate Cancer Consortium. PMID: 37370731; PMCID: PMC10295832.
        View in: PubMed   Mentions:
      12. Operational Ontology for Oncology (O3): A Professional Society-Based, Multistakeholder, Consensus-Driven Informatics Standard Supporting Clinical and Research Use of Real-World Data From Patients Treated for Cancer. Int J Radiat Oncol Biol Phys. 2023 11 01; 117(3):533-550. Mayo CS, Feng MU, Brock KK, Kudner R, Balter P, Buchsbaum JC, Caissie A, Covington E, Daugherty EC, Dekker AL, Fuller CD, Hallstrom AL, Hong DS, Hong JC, Kamran SC, Katsoulakis E, Kildea J, Krauze AV, Kruse JJ, McNutt T, Mierzwa M, Moreno A, Palta JR, Popple R, Purdie TG, Richardson S, Sharp GC, Satomi S, Tarbox LR, Venkatesan AM, Witztum A, Woods KE, Yao Y, Farahani K, Aneja S, Gabriel PE, Hadjiiski L, Ruan D, Siewerdsen JH, Bratt S, Casagni M, Chen S, Christodouleas JC, DiDonato A, Hayman J, Kapoor R, Kravitz S, Sebastian S, Von Siebenthal M, Bosch W, Hurkmans C, Yom SS, Xiao Y. PMID: 37244628; PMCID: PMC10741247.
        View in: PubMed   Mentions: 2     Fields:    Translation:Humans
      13. Impact of Squamous Histology on Clinical Outcomes and Molecular Profiling in Metastatic Urothelial Carcinoma Patients Treated With Immune Checkpoint Inhibitors or Enfortumab Vedotin. Clin Genitourin Cancer. 2023 10; 21(5):e394-e404. Jindal T, Zhang L, Deshmukh P, Reyes K, Chan E, Kumar V, Zhu X, Maldonado E, Feng S, Johnson M, Angelidakis A, Kwon D, Desai A, Borno HT, Bose R, Wong A, Hong J, Carroll P, Meng M, Porten S, Aggarwal R, Small EJ, Fong L, Chou J, Friedlander T, de Kouchkovsky I, Koshkin VS. PMID: 37316414.
        View in: PubMed   Mentions: 2     Fields:    Translation:Humans
      14. Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases. JAMA Netw Open. 2023 04 03; 6(4):e2310117. Carpenter DJ, Leng J, Arshad M, Giles W, Kirkpatrick JP, Floyd SR, Chmura SJ, Salama JK, Hong JC. PMID: 37099292; PMCID: PMC10134007.
        View in: PubMed   Mentions:    Fields:    Translation:Humans
      15. Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer. Eur Urol Oncol. 2023 Oct; 6(5):501-507. Sabbagh A, Washington SL, Tilki D, Hong JC, Feng J, Valdes G, Chen MH, Wu J, Huland H, Graefen M, Wiegel T, Böhmer D, Cowan JE, Cooperberg M, Feng FY, Roach M, Trock BJ, Partin AW, D'Amico AV, Carroll PR, Mohamad O. PMID: 36868922.
        View in: PubMed   Mentions: 2     Fields:    
      16. Healthcare provider evaluation of machine learning-directed care: reactions to deployment on a randomised controlled study. BMJ Health Care Inform. 2023 Feb; 30(1). Hong JC, Patel P, Eclov NCW, Stephens SJ, Mowery YM, Tenenbaum JD, Palta M. PMID: 36764680; PMCID: PMC9923272.
        View in: PubMed   Mentions: 1     Fields:    Translation:Humans
      17. Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic. JAMA Oncol. 2022 12 01; 8(12):1849-1851. Ragavan MV, Legaspi N, LaLanne A, Hong JC, Small EJ, Borno HT. PMID: 36301577; PMCID: PMC9614670.
        View in: PubMed   Mentions: 3     Fields:    Translation:HumansPHPublic Health
      18. Serial stereotactic body radiation therapy for oligometastatic prostate cancer detected by novel PET-based radiotracers. Urol Oncol. 2023 03; 41(3):145.e7-145.e15. Kwon DH, Shakhnazaryan N, Shui D, Hong JC, Mohamad O, de Kouchkovsky I, Borno HT, Bose R, Chou J, Desai A, Fong L, Friedlander TW, Koshkin VS, Aggarwal RR, Feng FY, Hope TA, Small EJ. PMID: 36435709.
        View in: PubMed   Mentions: 1     Fields:    Translation:Humans
      19. Assessing Unique Risk Factors for COVID-19 Complications Among Cancer Patients: A Multi-ethnic Cohort Study. J Immigr Minor Health. 2023 Jun; 25(3):624-633. Borno HT, Kim MO, Tolstykh I, Lin A, Hong JC, Yousefi S, Zhang S, McKay RR, Harismendy O, Razavi P, Cinar P, Rugo H, Koshkin VS, Rabow M, Wang C, Bailey A, Small EJ. PMID: 36344859; PMCID: PMC9640901.
        View in: PubMed   Mentions:    Fields:    Translation:HumansCells
      20. Prognostic Model for Intracranial Progression after Stereotactic Radiosurgery: A Multicenter Validation Study. Cancers (Basel). 2022 Oct 22; 14(21). Carpenter DJ, Natarajan B, Arshad M, Natesan D, Schultz O, Moravan MJ, Read C, Lafata KJ, Giles W, Fecci P, Mullikin TC, Reitman ZJ, Kirkpatrick JP, Floyd SR, Chmura SJ, Hong JC, Salama JK. PMID: 36358606; PMCID: PMC9657742.
        View in: PubMed   Mentions:
      21. Severe extra-glandular involvement and pleural effusions complicating primary Sjogren's syndrome: a case report. J Med Case Rep. 2022 Oct 18; 16(1):374. Abou Ziki MD, Taoutel R, Hong JC, Podell DN. PMID: 36253840; PMCID: PMC9578189.
        View in: PubMed   Mentions:    Fields:    Translation:Humans
      22. Implementation of machine learning in the clinic: challenges and lessons in prospective deployment from the System for High Intensity EvaLuation During Radiation Therapy (SHIELD-RT) randomized controlled study. BMC Bioinformatics. 2022 Sep 30; 23(Suppl 12):408. Hong JC, Eclov NCW, Stephens SJ, Mowery YM, Palta M. PMID: 36180836; PMCID: PMC9526253.
        View in: PubMed   Mentions: 1     Fields:    Translation:Humans
      23. A Clinical Reasoning-Encoded Case Library Developed through Natural Language Processing. J Gen Intern Med. 2023 01; 38(1):5-11. Zack T, Dhaliwal G, Geha R, Margaretten M, Murray S, Hong JC. PMID: 36071325; PMCID: PMC9849536.
        View in: PubMed   Mentions: 1     Fields:    Translation:Humans
      24. COVID-19 Outcomes Among Patients With Cancer: Observations From the University of California Cancer Consortium COVID-19 Project Outcomes Registry. Oncologist. 2022 05 06; 27(5):398-406. Borno HT, Kim MO, Hong JC, Yousefi S, Lin A, Tolstykh I, Zhang S, McKay RR, Harismendy O, Cinar P, Rugo H, Koshkin VS, Rabow M, Wang C, Bailey A, Small EJ. PMID: 35348771; PMCID: PMC9074994.
        View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
      25. Opportunities to use electronic health record audit logs to improve cancer care. Cancer Med. 2022 09; 11(17):3296-3303. Huilgol YS, Adler-Milstein J, Ivey SL, Hong JC. PMID: 35348298; PMCID: PMC9468426.
        View in: PubMed   Mentions: 4     Fields:    Translation:Humans
      26. COVID-19 outcomes in patients with cancer: Findings from the University of California health system database. Cancer Med. 2022 06; 11(11):2204-2215. Kwon DH, Cadena J, Nguyen S, Chan KHR, Soper B, Gryshuk AL, Hong JC, Ray P, Huang FW. PMID: 35261195; PMCID: PMC9110901.
        View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
      27. Strategies to Turn Real-world Data Into Real-world Knowledge. JAMA Netw Open. 2021 10 01; 4(10):e2128045. Hong JC. PMID: 34618043.
        View in: PubMed   Mentions: 11     Fields:    Translation:Humans
      28. Association of mental health diagnosis with race and all-cause mortality after a cancer diagnosis: Large-scale analysis of electronic health record data. Cancer. 2022 01 15; 128(2):344-352. Chen WC, Boreta L, Braunstein SE, Rabow MW, Kaplan LE, Tenenbaum JD, Morin O, Park CC, Hong JC. PMID: 34550601; PMCID: PMC8738115.
        View in: PubMed   Mentions: 5     Fields:    Translation:Humans
      29. An artificial intelligence framework integrating longitudinal electronic health records with real-world data enables continuous pan-cancer prognostication. Nat Cancer. 2021 07; 2(7):709-722. Morin O, Vallières M, Braunstein S, Ginart JB, Upadhaya T, Woodruff HC, Zwanenburg A, Chatterjee A, Villanueva-Meyer JE, Valdes G, Chen W, Hong JC, Yom SS, Solberg TD, Löck S, Seuntjens J, Park C, Lambin P. PMID: 35121948.
        View in: PubMed   Mentions: 18     Fields:    Translation:Humans
      30. Assessing Clinical Outcomes in a Data-Rich World-A Reality Check on Real-World Data. JAMA Netw Open. 2021 07 01; 4(7):e2117826. Hong JC, Butte AJ. PMID: 34309673.
        View in: PubMed   Mentions: 2     Fields:    
      31. Risk Stratification for Imminent Risk of Death at the Time of Palliative Radiotherapy Consultation. JAMA Netw Open. 2021 07 01; 4(7):e2115641. Wu SY, Yee E, Vasudevan HN, Fogh SE, Boreta L, Braunstein SE, Hong JC. PMID: 34196716; PMCID: PMC8251501.
        View in: PubMed   Mentions: 7     Fields:    Translation:Humans
      32. Disparities in Electronic Health Record Patient Portal Enrollment Among Oncology Patients. JAMA Oncol. 2021 06 01; 7(6):935-937. Sinha S, Garriga M, Naik N, McSteen BW, Odisho AY, Lin A, Hong JC. PMID: 33830178; PMCID: PMC8033503.
        View in: PubMed   Mentions: 14     Fields:    Translation:Humans
      33. Characterizing chronological accumulation of comorbidities in healthy veterans: a computational approach. Sci Rep. 2021 04 14; 11(1):8104. Hong JC, Hauser ER, Redding TS, Sims KJ, Gellad ZF, O'Leary MC, Hyslop T, Madison AN, Qin X, Weiss D, Bullard AJ, Williams CD, Sullivan BA, Lieberman D, Provenzale D. PMID: 33854078; PMCID: PMC8046765.
        View in: PubMed   Mentions: 2     Fields:    Translation:Humans
      34. Early salvage versus adjuvant therapy for treatment of prostate cancer following prostatectomy. BMJ Evid Based Med. 2021 12; 26(6):e8. Garriga M, Feng FY, Lee WR, Hong JC. PMID: 33361287.
        View in: PubMed   Mentions:    Fields:    Translation:Humans
      35. Natural language processing for abstraction of cancer treatment toxicities: accuracy versus human experts. JAMIA Open. 2020 Dec; 3(4):513-517. Hong JC, Fairchild AT, Tanksley JP, Palta M, Tenenbaum JD. PMID: 33623888; PMCID: PMC7886534.
        View in: PubMed   Mentions: 10  
      36. Closing the Gap Between Machine Learning and Clinical Cancer Care-First Steps Into a Larger World. JAMA Oncol. 2020 11 01; 6(11):1731-1732. Kang J, Morin O, Hong JC. PMID: 32970129.
        View in: PubMed   Mentions: 4     Fields:    Translation:Humans
      37. System for High-Intensity Evaluation During Radiation Therapy (SHIELD-RT): A Prospective Randomized Study of Machine Learning-Directed Clinical Evaluations During Radiation and Chemoradiation. J Clin Oncol. 2020 11 01; 38(31):3652-3661. Hong JC, Eclov NCW, Dalal NH, Thomas SM, Stephens SJ, Malicki M, Shields S, Cobb A, Mowery YM, Niedzwiecki D, Tenenbaum JD, Palta M. PMID: 32886536.
        View in: PubMed   Mentions: 26     Fields:    Translation:Humans
      38. High-Risk Adenomas at Screening Colonoscopy Remain Predictive of Future High-Risk Adenomas Despite an Intervening Negative Colonoscopy. Am J Gastroenterol. 2020 08; 115(8):1275-1282. Sullivan BA, Redding TS, Hauser ER, Gellad ZF, Qin X, Gupta S, Robertson DJ, Weiss DG, O'Leary MC, Madison AN, Sims KJ, Williams CD, Hong JC, Lieberman D, Provenzale D. PMID: 32483010.
        View in: PubMed   Mentions: 2     Fields:    Translation:Humans
      39. Interrater Reliability in Toxicity Identification: Limitations of Current Standards. Int J Radiat Oncol Biol Phys. 2020 08 01; 107(5):996-1000. Fairchild AT, Tanksley JP, Tenenbaum JD, Palta M, Hong JC. PMID: 32371073.
        View in: PubMed   Mentions: 8     Fields:    Translation:Humans
      40. Survival Advantage With Adjuvant Chemotherapy for Locoregionally Advanced Rectal Cancer: A Veterans Health Administration Analysis. J Natl Compr Canc Netw. 2020 01; 18(1):52-58. Spiegel DY, Boyer MJ, Hong JC, Williams CD, Kelley MJ, Salama JK, Palta M. PMID: 31910388.
        View in: PubMed   Mentions: 4     Fields:    Translation:Humans
      41. An Exploratory Radiomics Approach to Quantifying Pulmonary Function in CT Images. Sci Rep. 2019 08 08; 9(1):11509. Lafata KJ, Zhou Z, Liu JG, Hong J, Kelsey CR, Yin FF. PMID: 31395937; PMCID: PMC6687824.
        View in: PubMed   Mentions: 15     Fields:    Translation:Humans
      42. Authors' Reply. J Natl Compr Canc Netw. 2019 08 01; 17(8):xxxixa-xl. Hong JC, Salama JK. PMID: 31390591.
        View in: PubMed   Mentions:    Fields:    Translation:Humans
      43. Radiation Records in the National Cancer Database: Variations in Coding and/or Practice Can Significantly Alter Survival Results. JCO Clin Cancer Inform. 2019 05; 3:1-9. Jacobs CD, Carpenter DJ, Hong JC, Havrilesky LJ, Sosa JA, Chino JP. PMID: 31050906.
        View in: PubMed   Mentions: 10     Fields:    Translation:Humans
      44. Increasing PET Use in Small Cell Lung Cancer: Survival Improvement and Stage Migration in the VA Central Cancer Registry. J Natl Compr Canc Netw. 2019 02; 17(2):127-139. Hong JC, Boyer MJ, Spiegel DY, Williams CD, Tong BC, Shofer SL, Moravan MJ, Kelley MJ, Salama JK. PMID: 30787126.
        View in: PubMed   Mentions: 4     Fields:    Translation:Humans
      45. Association of pre-treatment radiomic features with lung cancer recurrence following stereotactic body radiation therapy. Phys Med Biol. 2019 01 08; 64(2):025007. Lafata KJ, Hong JC, Geng R, Ackerson BG, Liu JG, Zhou Z, Torok J, Kelsey CR, Yin FF. PMID: 30524018.
        View in: PubMed   Mentions: 20     Fields:    Translation:Humans
      46. Radiotherapy Treatment Planning in the Age of AI: Are We Ready Yet? Technol Cancer Res Treat. 2019 Jan-Dec; 18:1533033819894577. Zheng D, Hong JC, Wang C, Zhu X. PMID: 31858890; PMCID: PMC6927195.
        View in: PubMed   Mentions: 1     Fields:    Translation:Humans
      47. Artificial Intelligence in Radiotherapy Treatment Planning: Present and Future. Technol Cancer Res Treat. 2019 01 01; 18:1533033819873922. Wang C, Zhu X, Hong JC, Zheng D. PMID: 31495281; PMCID: PMC6732844.
        View in: PubMed   Mentions: 67     Fields:    Translation:Humans
      48. Predicting Emergency Visits and Hospital Admissions During Radiation and Chemoradiation: An Internally Validated Pretreatment Machine Learning Algorithm. JCO Clin Cancer Inform. 2018 12; 2:1-11. Hong JC, Niedzwiecki D, Palta M, Tenenbaum JD. PMID: 30652595.
        View in: PubMed   Mentions: 26     Fields:    Translation:Humans
      49. A Nomogram for Testosterone Recovery After Combined Androgen Deprivation and Radiation Therapy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2019 03 15; 103(4):834-842. Spiegel DY, Hong JC, Oyekunle T, Waters L, Lee WR, Salama JK, Koontz BF. PMID: 30419308.
        View in: PubMed   Mentions: 6     Fields:    Translation:Humans
      50. Spatial-temporal variability of radiomic features and its effect on the classification of lung cancer histology. Phys Med Biol. 2018 11 08; 63(22):225003. Lafata K, Cai J, Wang C, Hong J, Kelsey CR, Yin FF. PMID: 30272571.
        View in: PubMed   Mentions: 23     Fields:    Translation:Humans
      51. Long-term Clinical Outcomes of Nonoperative Management With Chemoradiotherapy for Locally Advanced Rectal Cancer in the Veterans Health Administration. Int J Radiat Oncol Biol Phys. 2019 03 01; 103(3):565-573. Spiegel DY, Boyer MJ, Hong JC, Williams CD, Kelley MJ, Moore H, Salama JK, Palta M. PMID: 30359718.
        View in: PubMed   Mentions: 2     Fields:    Translation:Humans
      52. Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC. Lung Cancer. 2018 11; 125:185-191. Ackerson BG, Tong BC, Hong JC, Gu L, Chino J, Trotter JW, D'Amico TA, Torok JA, Lafata K, Chang C, Kelsey CR. PMID: 30429018.
        View in: PubMed   Mentions: 14     Fields:    Translation:Humans
      53. High-volume providers and brachytherapy practice: A Medicare provider utilization and payment analysis. Brachytherapy. 2018 Nov - Dec; 17(6):906-911. Hong JC, Spiegel DY, Havrilesky LJ, Chino JP. PMID: 30057292.
        View in: PubMed   Mentions: 1     Fields:    Translation:Humans
      54. Intratreatment Response Assessment With 18F-FDG PET: Correlation of Semiquantitative PET Features With Pathologic Response of Esophageal Cancer to Neoadjuvant Chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2018 11 15; 102(4):1002-1007. Tandberg DJ, Cui Y, Rushing CN, Hong JC, Ackerson BG, Marin D, Zhang X, Czito BG, Willett CW, Palta M. PMID: 30055238.
        View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
      55. Association of Interim FDG-PET Imaging During Chemoradiation for Squamous Anal Canal Carcinoma With Recurrence. Int J Radiat Oncol Biol Phys. 2018 11 15; 102(4):1046-1051. Hong JC, Cui Y, Patel BN, Rushing CN, Faught AM, Eng JS, Higgins K, Yin FF, Das S, Czito BG, Willett CG, Palta M. PMID: 29891206.
        View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
      56. Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis. PLoS One. 2018; 13(4):e0195149. Hong JC, Ayala-Peacock DN, Lee J, Blackstock AW, Okunieff P, Sung MW, Weichselbaum RR, Kao J, Urbanic JJ, Milano MT, Chmura SJ, Salama JK. PMID: 29649281; PMCID: PMC5896920.
        View in: PubMed   Mentions: 46     Fields:    Translation:Humans
      57. Data-Derived Treatment Duration Goal for Cervical Cancer: Should 8 Weeks Remain the Target in the Era of Concurrent Chemoradiation? JCO Clin Cancer Inform. 2017 11; 1:1-15. Hong JC, Foote J, Broadwater G, Sosa JA, Gaillard S, Havrilesky LJ, Chino JP. PMID: 30657372.
        View in: PubMed   Mentions: 11     Fields:    Translation:Humans
      58. Mid-radiotherapy PET/CT for prognostication and detection of early progression in patients with stage III non-small cell lung cancer. Radiother Oncol. 2017 11; 125(2):338-343. Gensheimer MF, Hong JC, Chang-Halpenny C, Zhu H, Eclov NCW, To J, Murphy JD, Wakelee HA, Neal JW, Le QT, Hara WY, Quon A, Maxim PG, Graves EE, Olson MR, Diehn M, Loo BW. PMID: 28830717.
        View in: PubMed   Mentions: 16     Fields:    Translation:Humans
      59. Radiation dose and cardiac risk in breast cancer treatment: An analysis of modern radiation therapy including community settings. Pract Radiat Oncol. 2018 May - Jun; 8(3):e79-e86. Hong JC, Rahimy E, Gross CP, Shafman T, Hu X, Yu JB, Ross R, Finkelstein SE, Dosoretz A, Park HS, Soulos PR, Evans SB. PMID: 28888675.
        View in: PubMed   Mentions: 18     Fields:    Translation:Humans
      60. Increased Number of Beam Angles Is Associated With Higher Cardiac Dose in Adjuvant Fixed Gantry Intensity Modulated Radiation Therapy of Left-Sided Breast Cancer. Int J Radiat Oncol Biol Phys. 2017 12 01; 99(5):1137-1145. Rahimy E, Hong JC, Gross CP, Hu X, Soulos PR, Shafman T, Connor HJ, Ross R, Yu JB, Dosoretz A, Evans SB. PMID: 28864402.
        View in: PubMed   Mentions: 3     Fields:    Translation:Humans
      61. Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus. Int J Gynecol Cancer. 2017 05; 27(4):720-729. Hong JC, Foote J, Broadwater G, Gaillard S, Havrilesky LJ, Chino JP. PMID: 28375927.
        View in: PubMed   Mentions: 7     Fields:    Translation:Humans
      62. Primary Versus Preoperative Radiation for Locally Advanced Vulvar Cancer. Int J Gynecol Cancer. 2017 05; 27(4):794-804. Natesan D, Hong JC, Foote J, Sosa JA, Havrilesky L, Chino J. PMID: 28333840.
        View in: PubMed   Mentions: 11     Fields:    Translation:Humans
      63. The expanding role of stereotactic body radiation therapy in oligometastatic solid tumors: What do we know and where are we going? Cancer Treat Rev. 2017 Jan; 52:22-32. Hong JC, Salama JK. PMID: 27886588.
        View in: PubMed   Mentions: 13     Fields:    Translation:Humans
      64. A current perspective on stereotactic body radiation therapy for pancreatic cancer. Onco Targets Ther. 2016; 9:6733-6739. Hong JC, Czito BG, Willett CG, Palta M. PMID: 27826200; PMCID: PMC5096771.
        View in: PubMed   Mentions: 6  
      65. Chest Wall Deformity in the Radiation Oncology Clinic. Anticancer Res. 2016 10; 36(10):5295-5300. Stahl JM, Hong JC, Lester-Coll NH, Kann BH, Wilson LD, Higgins SA, Evans SB. PMID: 27798891.
        View in: PubMed   Mentions: 2     Fields:    Translation:Humans
      66. Dose escalation for unresectable locally advanced non-small cell lung cancer: end of the line? Transl Lung Cancer Res. 2016 Feb; 5(1):126-33. Hong JC, Salama JK. PMID: 26958507; PMCID: PMC4758964.
        View in: PubMed   Mentions: 4  
      67. Radiation therapy in the treatment of minor salivary gland tumors. Am J Clin Oncol. 2014 Oct; 37(5):492-7. Salgado LR, Spratt DE, Riaz N, Romesser PB, Wolden S, Rao S, Chin C, Hong JC, Wong R, Lee NY. PMID: 23428950; PMCID: PMC4498950.
        View in: PubMed   Mentions: 8     Fields:    Translation:Humans
      68. Irradiation for locoregionally recurrent, never-irradiated oral cavity cancers. Head Neck. 2015 Nov; 37(11):1633-41. Lok BH, Chin C, Riaz N, Ho F, Hu M, Hong JC, Shi W, Zhang Z, Sherman E, Wong RJ, Morris LG, Ganly I, Wolden SL, Rao SS, Lee NY. PMID: 24954094; PMCID: PMC4973396.
        View in: PubMed   Mentions: 5     Fields:    Translation:Humans
      69. Pulmonary ventilation imaging based on 4-dimensional computed tomography: comparison with pulmonary function tests and SPECT ventilation images. Int J Radiat Oncol Biol Phys. 2014 Oct 01; 90(2):414-22. Yamamoto T, Kabus S, Lorenz C, Mittra E, Hong JC, Chung M, Eclov N, To J, Diehn M, Loo BW, Keall PJ. PMID: 25104070; PMCID: PMC8112248.
        View in: PubMed   Mentions: 35     Fields:    Translation:Humans
      70. A nomogram to predict loco-regional control after re-irradiation for head and neck cancer. Radiother Oncol. 2014 Jun; 111(3):382-7. Riaz N, Hong JC, Sherman EJ, Morris L, Fury M, Ganly I, Wang TJ, Shi W, Wolden SL, Jackson A, Wong RJ, Zhang Z, Rao SD, Lee NY. PMID: 24993329; PMCID: PMC5125394.
        View in: PubMed   Mentions: 33     Fields:    Translation:Humans
      71. Combined-modality therapy for rectal cancer: analysis of potential differences in disease presentation, treatment adherence, and treatment outcome according to race. Am J Clin Oncol. 2014 Apr; 37(2):122-5. Tonlaar N, Song S, Hong JC, Minsky BD, Chang DT, Polite BN, Liauw SL. PMID: 23211225.
        View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
      72. Risk of cerebrovascular events in elderly patients after radiation therapy versus surgery for early-stage glottic cancer. Int J Radiat Oncol Biol Phys. 2013 Oct 01; 87(2):290-6. Hong JC, Kruser TJ, Gondi V, Mohindra P, Cannon DM, Harari PM, Bentzen SM. PMID: 23906930.
        View in: PubMed   Mentions: 15     Fields:    Translation:Humans
      73. Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis. Ann Surg Oncol. 2013 Nov; 20(12):3999-4007. Hong JC, Murphy JD, Wang SJ, Koong AC, Chang DT. PMID: 23800897.
        View in: PubMed   Mentions: 13     Fields:    Translation:Humans
      74. Migration of implanted markers for image-guided lung tumor stereotactic ablative radiotherapy. J Appl Clin Med Phys. 2013 Mar 04; 14(2):4046. Hong JC, Eclov NC, Yu Y, Rao AK, Dieterich S, Le QT, Diehn M, Sze DY, Loo BW, Kothary N, Maxim PG. PMID: 23470933; PMCID: PMC5714376.
        View in: PubMed   Mentions: 8     Fields:    Translation:Humans
      75. An automated method for comparing motion artifacts in cine four-dimensional computed tomography images. J Appl Clin Med Phys. 2012 Nov 08; 13(6):3838. Cui G, Jew B, Hong JC, Johnston EW, Loo BW, Maxim PG. PMID: 23149777; PMCID: PMC5718547.
        View in: PubMed   Mentions: 7     Fields:    Translation:Humans
      76. Reproducibility of four-dimensional computed tomography-based lung ventilation imaging. Acad Radiol. 2012 Dec; 19(12):1554-65. Yamamoto T, Kabus S, von Berg J, Lorenz C, Chung MP, Hong JC, Loo BW, Keall PJ. PMID: 22975070; PMCID: PMC5357435.
        View in: PubMed   Mentions: 24     Fields:    Translation:Humans
      77. Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence. Ann Surg Oncol. 2012 Aug; 19(8):2471-6. Song S, Hong JC, McDonnell SE, Koong AC, Minsky BD, Chang DT, Liauw SL. PMID: 22327251.
        View in: PubMed   Mentions: 13     Fields:    Translation:Humans
      78. High retention and safety of percutaneously implanted endovascular embolization coils as fiducial markers for image-guided stereotactic ablative radiotherapy of pulmonary tumors. Int J Radiat Oncol Biol Phys. 2011 Sep 01; 81(1):85-90. Hong JC, Yu Y, Rao AK, Dieterich S, Maxim PG, Le QT, Diehn M, Sze DY, Kothary N, Loo BW. PMID: 20675070.
        View in: PubMed   Mentions: 10     Fields:    Translation:Humans
      Julian's Networks
      Concepts (226)
      Derived automatically from this person's publications.
      Explore
      _
      Co-Authors (71)
      People in Profiles who have published with this person.
      Explore
      _
      Similar People (60)
      People who share similar concepts with this person.
      Explore
      _
      Same Department
      Search Department
      _

      UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

      We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-5-g94c7c43e on PROFILES-PWEB03.

      Copyright © The Regents of the University of California.